Routes for Drug Delivery to the Eye and Retina: Intravitreal Injections
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
The advantage of intravitreal injections is an immediate and increased therapeutic effect in the intended retinal tissue. The accuracy, precision and reproducibility of the delivered volume depend on the size of the syringe and the physician's manual experience. The eyelids and eyelashes are usually disinfected using a povidone-iodine solution (10%); a sterile speculum is placed and drops of povidone-iodine (5%) are applied. The use of adequate anesthetic topical lidocaine 2% is required. The injection site should be located 3.5-4 mm posterior to the limbus. The angle of the incision through the sclera may be directed in an oblique fashion of 30°. The diameter of the needle should be smaller than 25 G, and the injected volume should be limited to 0.15 ml without a routine paracentesis. The incidence of lens injury is 0.006% (2/32,318) and 0.013% (5/35,942) for rhegmatogenous retinal detachments. The rate of suspected endophthalmitis is 0.018% after bevacizumab and 0.027% after ranibizumab injections. Sterile inflammations have been observed after Avastin injections. The concentrations of vascular endothelial growth factor inhibitors decline in a monoexponential fashion. The half-life of unbound bevacizumab is 9.82 days and that of ranibizumab 7.19 days.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liu, L., Ammar, D. A., Ross, L. A., Mandava, N., Kahook, M. Y., & Carpenter, J. F. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-6431 · Cited by 199
Intraocular inflammation following intravitreal injection of bevacizumab
Bakri, S. J., Larson, T. A., & Edwards, A. O. (2008) · Graefe's Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-007-0754-7 · Cited by 102
Cited by
Hydrogel-based commercial products for biomedical applications: A review
Cascone, S., & Lamberti, G. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118803 · Cited by 421
Xu, M., Fan, R., Fan, X., Shao, Y., & Li, X. (2022) · Drug Design, Development and Therapy · doi:10.2147/dddt.s383101 · Cited by 111
Complications of intravitreal injections: 2022
Patel, D., Patel, S. N., Chaudhary, V., & Garg, S. J. (2022) · Current Opinion in Ophthalmology · doi:10.1097/icu.0000000000000850 · Cited by 92
Olaparib significantly delays photoreceptor loss in a model for hereditary retinal degeneration
Sahaboglu, A., Barth, M., Secer, E., Amo, E. M. D., Urtti, A., Arsenijevic, Y., Zrenner, E., & Paquet-Durand, F. (2016) · Scientific Reports · doi:10.1038/srep39537 · Cited by 53
Salman, A., Kantor, A., McClements, M. E., Marfany, G., Trigueros, S., & MacLaren, R. E. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14091842 · Cited by 37
Metadata
- Authors
- Meyer, C. H., Krohne, T. U., Charbel Issa, P., Liu, Z., & Holz, F. G.
- Venue
- Developments in Ophthalmology
- Publisher
- S. Karger AG
- Published
- 2015-10-26
- Volume
- 55
- Pages
- 63-70
- ISSN
- 0250-3751 (ISSN-L)
- 1662-2790
- OpenAlex
- W1827004932
- Cited by
- 57
- References
- 2
- FWCI
- 19.13
- Type
- book chapter
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Routes for Drug Delivery to the Eye and Retina: Intravitreal Injections. https://app.cochat.ai/papers/10.1159/000431143
- The paper
- Meyer, C. H., Krohne, T. U., Charbel Issa, P., Liu, Z., & Holz, F. G. (2016). Routes for Drug Delivery to the Eye and Retina: Intravitreal Injections. Developments in Ophthalmology. https://doi.org/10.1159/000431143
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.